Creating a device to quickly detect SARS-CoV-2 in the air
Official title: Development of a handheld rapid air sensing system to monitor and quantify SARS-CoV-2 in aerosols in real-time
Funded at Genendeavor, LLC · NIH-10273983 · Data updated 2026-11-12
This study is working on a handy device that can quickly check the air for the presence of the COVID-19 virus, making it easier for places like schools and offices to stay safe as they reopen.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Genendeavor, LLC NIH-funded |
| Lab location | 1 site (Hayward, UNITED STATES) |
| Project start | September 20, 2021 |
| Project end | August 31, 2025 |
| Funding year | 2021 |
| Award (this year) | $2,723,214 |
| NIH project number | 1R01DE031927-01 |
| Project ID | NIH-10273983 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals in community settings, such as schools and workplaces, where monitoring air quality for SARS-CoV-2 is essential.
✕Less likely to help
Patients who are not in environments where aerosol transmission is a concern may not benefit from this research.
What this research studies
This research focuses on developing a handheld device that can monitor and quantify the presence of SARS-CoV-2 in aerosol particles in real-time. By utilizing advanced technologies such as rapid-kinetic chemical auto-ligation and solid-state electronics, the project aims to provide a simple and efficient way to detect the virus in the air, which is crucial for managing airborne transmission risks as communities reopen. The device will allow for immediate results without the need for complex laboratory equipment, making it accessible for use in various settings like schools and workplaces.
Why it matters
Potential benefit: If successful, this research could significantly enhance the ability to monitor and control the spread of COVID-19 in public spaces.
How similar studies have gone: While there have been advancements in air monitoring technologies, this specific approach to real-time detection of SARS-CoV-2 in aerosols is novel and has not been extensively tested.
Where this research is happening
-
Genendeavor, LLC
Hayward, United States Active
Researchers
- Principal investigator: Mancebo, Ricardo — Genendeavor, LLC
- Study coordinator: Mancebo, Ricardo
Related research
Other NIH-funded projects on the same topics.
-
How COVID-19 infection and genes may influence memory and dementia risk
This study looks at how getting COVID-19 and a person’s genes together affect the chance of developing memory problems and Alzheimer’s disease later in life.
-
Understanding flu and COVID-19 vaccine responses in people and in the lab
Researchers at Stanford explore how flu and COVID-19 vaccines work in people and in lab tests to improve protection for adults.
-
Oral small molecule inhibitors to block SARS-CoV-2 RNA replication
A Stanford-led project tests a pill that could stop SARS-CoV-2 and related viruses from copying their RNA inside infected cells.
-
Outpatient antiviral cocktails to fight SARS-CoV-2 and future RNA viruses
Researchers at Stanford are developing outpatient antiviral cocktails that could be used easily outside the hospital to treat COVID-19 and future RNA virus infections.
-
Inhibitors for SARS-CoV-2 Proteases to Block Viral Replication
A patient-facing program aims to discover and optimize small molecules that block key SARS-CoV-2 enzymes, potentially reducing viral replication.
-
How different COVID-19 vaccines shape immune responses
This project compares immune reactions after mRNA and adenoviral COVID-19 vaccines to learn how long protection lasts and why some people get breakthrough infections or side effects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.